Upload Avatar (500 x 500)
Wen Sheng Wei
wswei (AT) pku.edu.cn
English, Chinese
Beijing
Peking University
Life Sciences
  • 1999 - 2004 Postdoctoral Fellow, Genetics, Stanford University
  • 1995 - 1999 PhD, Genetics, Michigan State University
  • 1987 - 1991 Bachelor of Science, Biochemistry, Peking University
  • 2019 - Present Professor (tenure), Peking University College of Life Sciences
  • 2016 - Present Researcher, Beijing Future Gene Diagnosis Innovation Center (ICG)
  • 2015 - Present Researcher, Peking-Tsinghua Center for Life Sciences (CLS)
  • 2014 - Present Researcher, Peking University Biomedical Innovation Institute (BIOPIC)
  • 2007 - Present Researcher, Peking University College of Life Sciences, Biochemistry and Molecular Biology
  • 2005 - 2007 Research Associate, Stanford University School of Medicine, Department of Genetics
  • 1999 - 2004 Postdoctoral Fellow, Stanford University School of Medicine, Department of Genetics
  • Beijing Advanced Worker, 2020
  • Changju Project Entrepreneurial Talent, 2020
  • Major Medical Advancements in China Award, 2019
  • Beijing Overseas Scholars Innovation and Entrepreneurship Special Contribution Award, 2019
  • BI Investigatorship Award, 2019
  • Peking University College of Life Sciences Unnamed Outstanding Research Award, 2019
  • Fourth Peking University Industry-Academia-Research Cooperation Advanced Individual Award, 2019
  • Beijing Science and Technology Award, 2018
  • China Ministry of Science and Technology Innovation Talent Promotion Plan Science and Technology Innovation Entrepreneur Talent, 2018
  • Peking University Teaching Excellence Award, 2018
  • Tan Jiazhen Life Science Innovation Award, 2016
  • China Patent Excellence Award, 2016
  • Scientific Chinese Person of the Year, 2016
  • Peking University Zheng Changxue Teaching Excellence Award, 2015
  • Bayer Investigator Award, 2014
  • The Roche Chinese Young Investigator Award, 2014
  • Peking University Dongbao Teaching Award, 2012
  • Most Popular Teacher Award, Peking University College of Life Sciences, 2010
Gene editing technology
Novel gene therapy and vaccine technology
High-throughput functional genomics
Molecular mechanisms of major diseases
  • Circular RNA Vaccines against SARS-CoV-2 and Emerging Variants, Wei W* et al., 2022
  • Regulatory elements can be essential for maintaining broad chromatin organization and cell viability, Wei W* et al., 2022
  • Gene editing and its applications in biomedicine, Wei W* et al., 2022
  • Engineered circular ADAR-recruiting RNAs increase the efficiency and fidelity of RNA editing in vitro and in vivo, Wei W* et al., 2022
  • Non-coding loci without epigenomic signals can be essential for maintaining global chromatin organization and cell viability, Wei W* et al., 2021
  • Sensing of cytoplasmic chromatin by cGAS activates innate immune response in SARS-CoV-2 infection, Wei W* et al., 2021
  • Genome-wide CRISPR activation screen identifies candidate receptors for SARS-CoV-2 entry, Wei W* et al., 2021
  • Low-density lipoprotein receptor-related protein 1 is a CROPs-associated receptor for Clostridioides difficile toxin B, Wei W* et al., 2021
  • Genome-wide interrogation of gene functions through base editor screens empowered by barcoded sgRNAs, Wei W* et al., 2021
  • TRIM26 is a critical host factor for HCV replication and determines host tropism, Wei W* et al., 2021
  • Reply to: Fitness effects of CRISPR/Cas9-targeting of long noncoding RNA genes, Wei W* et al., 2020
  • Structural insights into the specific recognition of 5-methylcytosine and 5-hydroxymethylcytosine by TAL effectors, Wei W* et al., 2019
  • PASTMUS: mapping functional elements at single amino acid resolution in human cells, Wei W* et al., 2019
  • Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs, Wei W* et al., 2019
  • Human Neonatal Fc Receptor Is the Cellular Uncoating Receptor for Enterovirus B, Wei W* et al., 2019
  • Guide RNAs with embedded barcodes boost CRISPR-pooled screens, Wei W* et al., 2019
  • Genome-wide screening for functional long noncoding RNAs in human cells by Cas9 targeting of splice sites, Wei W* et al., 2018
  • A surrogate reporter system for multiplexable evaluation of CRISPR/Cas9 in targeted mutagenesis, Wei W* et al., 2018
  • Deciphering TAL effectors for 5-methylcytosine and 5-hydroxymethylcytosine recognition, Wei W* et al., 2017
  • Glucosyltransferase Activity of Clostridium difficile Toxin B Triggers Autophagy-mediated Cell Growth Arrest, Wei W* et al., 2017
  • Painting A Specific Chromosome with CRISPR/Cas9 for Live-cell Imaging, Wei W* et al., 2017
  • Live visualization of genomic loci with BiFC-TALE, Wei W* et al., 2017
  • Simultaneous generation of multi-gene knockouts in human cells, Wei W* et al., 2016
  • Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR library, Wei W* et al., 2016
  • High-throughput Screens in Mammalian Cells Using the CRISPR-Cas9 System, Wei W* et al., 2015
  • Divergent roles of BECN1 in LC3 lipidation and autophagosomal function, Wei W* et al., 2015
  • A Dual-Reporter System for Real-Time Monitoring and High-throughput CRISPR/Cas9 Library Screening of the Hepatitis C Virus, Wei W* et al., 2015
  • Chondroitin sulfate proteoglycan 4 functions as the cellular receptor for Clostridium difficile toxin B, Wei W* et al., 2015
  • High-throughput Screening of a CRISPR/Cas Library for Functional Genomics in Human Cells, Wei W* et al., 2014
  • Bidirectional effect of Wnt signaling antagonist DKK1 on the modulation of anthrax toxin uptake
Crispr Cas9 Gene Therapy Vaccines High-Throughput Genomics Disease Mechanisms Cancer Infections Molecular Biology

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.